Advertisement

Ads Placeholder
Loading...

Danaher Corporation

DHR•NYSE
Healthcare
Medical - Diagnostics & Research
$191.12
$0.33(0.17%)
U.S. Market opens in 19h 53m

Danaher Corporation (DHR) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap135.1B
P/E Ratio37.40
EPS (TTM)$5.03
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$185.02
3 Months$178.96
1 Year Target$219.51

DHR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.05, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $219.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 37.40 and a market capitalization of 135.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.17%
5-Day Change
3.46%
1-Month Change
-6.32%
3-Month Change
-17.05%
6-Month Change
-11.10%
Year-to-Date (YTD) Change
-17.05%
1-Year Change
-3.43%
3-Year Change
-13.79%
5-Year Change
-4.82%
All-Time (Max) Change
31982.72%

Contact Information

https://www.danaher.com
202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

610,000 Employees
IPO DateDec 29, 1978
CountryUS
Actively Trading

Frequently Asked Questions